Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

News Daily News

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

July 25, 2025

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

Use of Secondary CVD Prevention Meds Still Meager Worldwide

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

February 03, 2025

Stop-or-Not It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

August 30, 2024

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

News Daily News

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Yael L. Maxwell

August 08, 2024

July 2023 News Roundup

News Opinion CV Team Dispatch

July 2023 News Roundup

July 01, 2023

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

February 02, 2023

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

News Daily News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

January 13, 2021

Across Europe, Data Confirm ‘Missing STEMIs’ in COVID-19 Era

News Daily News

Across Europe, Data Confirm ‘Missing STEMIs’ in COVID-19 Era

November 09, 2020

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

News Conference News ESC 2020

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

Michael O'Riordan

September 04, 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

News Conference News ESC 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

August 31, 2020

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

January 19, 2017

News Daily News

Blood Pressures Measured at Home Better Predict CAD Events Than Do Clinic Readings

March 29, 2016

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

March 20, 2014

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

September 04, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.